Deciphera To Present At Future Leaders In The Biotech Industry Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on developing advanced kinase inhibitor treatments targeting the tumor cell and the tumor microenvironment, today announced that Michael D. Taylor, Ph.D., Deciphera’s President and Chief Executive Officer will present a corporate update at the upcoming 23rd Annual Future Leaders in the Biotech Industry Conference on Friday, March 11, 2016 at 1:30 p.m. ET in New York.

Back to news